美国食品和药物管理局批准FluMist鼻流感疫苗在2025年秋季开始在家中使用,适用于2至49岁的儿童. FDA approves FluMist nasal flu vaccine for at-home use for ages 2-49, starting fall 2025.

美国食品和药物管理局批准使用FluMist,一种鼻流感疫苗,从2025年秋季开始在家中使用. The FDA has approved FluMist, a nasal flu vaccine, for at-home use starting in fall 2025. 这种活疫苗适合2-49岁的人使用,通过鼻鼻喷剂进行接种。 This live vaccine is suitable for individuals aged 2 to 49 and is administered via nasal spray. 它与传统疫苗一样有效,但对于免疫腐蚀者或有喘息史的人却不推荐使用。 It is as effective as traditional vaccines but not recommended for those who are immunocompromised or have a history of wheezing. 使用者应避免两周前使用抗病毒药物,如果家里有免疫不良的人,应谨慎行事。 Users should avoid antiviral medications two weeks prior and be cautious if immunodeficient individuals are present in the home.